SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of NextGen Healthcare; Are NXGN Shareholders Getting a Fair Deal

September 08, 2023 10:20 AM EDT | Source: Johnson Fistel, LLP

San Diego, California--(Newsfile Corp. - September 8, 2023) - Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of NextGen Healthcare, Inc. (NASDAQ: NXGN) ("NextGen") breached their fiduciary duties in connection with the proposed sale of the Company to Thoma Bravo.

You can click or copy and paste the following link to join this investigation:

https://www.cognitoforms.com/JohnsonFistel/NextGenHealthcareInc

On September 6, 2023, NextGen announced that it had entered a deal to be purchased by Thoma Bravo. Under the terms of this agreement, shareholders will receive $23.95 per share in an all-cash offer.

The investigation concerns whether the NextGen board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for NextGen shares of common stock. Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given analysts' projections for future earnings and revenue growth.

If you are a shareholder of NextGen and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
Investor Relations
jimb@johnsonfistel.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/180030

info